Table 3.
Response and Outcomes of ELT vs. standard (non-ELT) treatment in immune thrombocytopenia and acquired idiopathic aplastic anemia.
| Characteristic | ELT (n = 61) | Non-ELT (n = 60) | p-value | ||
|---|---|---|---|---|---|
| IAA | ITP | IAA | ITP | ||
| Median Hb pre-treatment (g/dl) | 7.6 | 11.3 | 7.5 | 11.1 | 0.045 |
| Median Hb post-treatment (g/dl) | 11.1 | 12.5 | 9.2 | 12.1 | 0.033 |
| Median WBC pre-treatment (10E9/L) | 1.4 | 3.0 | 3.0 | 7.9 | 0.042 |
| Median WBC post-treatment (10E9/L) | 6.9 | 14.0 | 3.5 | 10.9 | 0.038 |
| Median Platelets pre-treatment (10E9/L) | 9 | 6 | 12 | 12 | 0.028 |
| Median Platelets post-treatment (10E9/L) | 70 | 166 | 19 | 128 | 0.021 |
| Response No Yes |
15 (46.9%) 17 (53.1%) |
4 (13.8%) 25 (86.2%) |
26 (86.7%) 4 (13.3%) |
7 (23.3%) 23 (76.7%) |
0.0006 |